ストックスクリーナーアプリを入手
14.15
2.91%
0.40
前日終値:
$13.75
開ける：
$13.88
24時間の取引高:
3.41M
Relative Volume:
1.02
時価総額：
$11.79B
収益：
$3.81B
当期純損益:
$485.75M
株価収益率:
24.09
EPS:
0.5873
ネットキャッシュフロー:
$175.50M
1週間 パフォーマンス:
+7.28%
1か月 パフォーマンス:
+13.11%
6か月 パフォーマンス:
+0.86%
1年 パフォーマンス:
-3.08%
1日の値動き範囲:
$13.69
$14.24
1週間の範囲:
$13.05
$14.24
52週間の値動き範囲:
$11.36
$15.67
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
Compare RDY vs TAK, TEVA, HLN, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RDY
Dr Reddys Laboratories Ltd Adr
|
14.15 | 11.79B | 3.81B | 485.75M | 175.50M | 0.5873 |
TAK
Takeda Pharmaceutical Co Adr
|
20.15 | 64.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.97 | 46.62B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.00 | 43.98B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
77.80 | 32.15B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
586.48 | 25.15B | 3.17B | 1.29B | 1.01B | 27.09 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-10-26 | アップグレード | JP Morgan | Underweight → Neutral |
| 2026-10-26 | アップグレード | Jefferies | Underperform → Hold |
| 2026-09-29 | アップグレード | Citigroup | Sell → Buy |
| 2026-04-23 | ダウングレード | Goldman | Neutral → Sell |
| 2025-06-05 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-12-19 | ダウングレード | Nomura | Buy → Neutral |
| 2024-01-11 | ダウングレード | Jefferies | Buy → Underperform |
| 2023-08-29 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-05-18 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-03-17 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-01-30 | 開始されました | JP Morgan | Underweight |
| 2022-11-14 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2022-01-03 | 再開されました | BofA Securities | Neutral |
| 2021-07-27 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2021-02-02 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-09-18 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-09-18 | アップグレード | Investec | Sell → Hold |
| 2020-01-28 | ダウングレード | CLSA | Buy → Outperform |
| 2020-01-27 | ダウングレード | CLSA | Buy → Outperform |
| 2020-01-09 | アップグレード | Citigroup | Sell → Buy |
| 2019-11-04 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-09-04 | アップグレード | Credit Suisse | Underperform → Outperform |
| 2019-07-01 | アップグレード | Macquarie | Neutral → Outperform |
| 2019-06-20 | 開始されました | Deutsche Bank | Hold |
| 2019-06-11 | 開始されました | Barclays | Equal Weight |
| 2019-05-20 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-02-19 | アップグレード | CLSA | Outperform → Buy |
| 2019-01-17 | ダウングレード | Citigroup | Neutral → Sell |
| 2017-09-21 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-08-31 | アップグレード | CLSA | Underperform → Outperform |
| 2017-07-28 | ダウングレード | CLSA | Underperform → Sell |
| 2016-07-27 | ダウングレード | HSBC Securities | Hold → Reduce |
| 2016-07-27 | ダウングレード | Jefferies | Hold → Underperform |
| 2016-02-10 | アップグレード | Credit Agricole | Underperform → Buy |
| 2015-11-10 | ダウングレード | Citigroup | Buy → Neutral |
すべてを表示
Dr Reddys Laboratories Ltd Adr (RDY) 最新ニュース
RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales Fall - Zacks Investment Research
Dr. Reddy's Laboratories: 3 Key Takeaways for Long-Term Investors - The Motley Fool
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading - Yahoo Finance
Top Stock Reports for Oracle, American Express & Progressive - Zacks Investment Research
Dr. Reddy's Laboratories Shares Rise After BNP Paribas Upgrade - www.marketscreener.com
Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - Yahoo Finance
Pomerantz LLP investigates Dr. Reddy's over semaglutide-linked losses - scanx.trade
Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; End Week Flat - Yahoo Finance
Global Substance Use Disorder Treatment Market Analysis and Forecast to 2030 | Long-Acting Therapies, Telemedicine, and Drug Innovation Drive Growth - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - finance.yahoo.com
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - Yahoo! Finance Canada
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Down for Week - Yahoo Finance
HDFC Bank Limited (HDB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Wipro Limited (WIT) Stock Price, News, Quote & History - Yahoo! Finance Canada
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy’s Laboratories LimitedRDY - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc.EBS - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - Yahoo Finance
Dr. Reddy's probed for fraud after ₹2.4bn semaglutide hit - scanx.trade
Dr Reddy's Laboratories stock gains attention on QDENGA vaccine deal - AD HOC NEWS
Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Up Marginally for Week - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading - Yahoo Finance
Dr. Reddy's faces fifth US securities probe after semaglutide hit - scanx.trade
Asian Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - finance.yahoo.com
Dr. Reddy’s Issues New ESOP Shares After ADR Option Exercise - TipRanks
Dr. Reddy’s (NYSE: RDY) adds 375 shares via employee options - Stock Titan
Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - Yahoo Finance
Dr. Reddy's Laboratories (RDY) Holds at $11.9 as Shares Consolidate Between Key LevelsPCR Mean Reversion - siam.in
Dr. Reddy’s ADR tests $11.70 support after bearish close: Live levels - Investing.com India
Asian Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - Yahoo Finance
Dr. Reddy’s ADR tests key support 4th time: Live levels By Investing.com - Investing.com India
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - Yahoo Finance
GLP-1 sales in Canada on pace to set a new record this year - The Globe and Mail
Dr. Reddy’s (NYSE: RDY) issues 4,110 stock-option shares - Stock Titan
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - Yahoo Finance
Dr. Reddy’s Labs ADR trapped in no-trade zone: Live levels - Investing.com India
Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading - Yahoo Finance
Dr. Reddy’s ADR tests ₹12.00 support: Live levels By Investing.com - Investing.com India
symbol__ Stock Quote Price and Forecast - CNN
ETFs Investing in Dr. Reddy's Laboratories Ltd. Sponsored ADR Stocks - TradingView
Asian Equities Traded in the US as American Depositary Receipts Marginally Higher in Thursday Trading - Yahoo Finance
Dr Reddys Laboratories Ltd Adr (RDY) 財務データ
収益
当期純利益
現金流量
EPS
0.00%
0.32%
大文字化:
|
ボリューム (24 時間):